Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Milchert

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Medicina (Kaunas, Lithuania)|April 30, 2021
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell ArteritisCiro Manzo, Maria Maslinska, Alberto Castagna, et al.
Rheumatology International|May 13, 2026
Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohortNelly Ziade, Ihsane Hmamouchi, Marc Moussallem, et al.
Frontiers in Medicine|August 22, 2024
Increased interest with the introduction of fast-track diagnostic pathway is associated with the regionally increased frequency of giant cell arteritis in Poland: a study based on POLVAS registry dataMarcin Milchert, Krzysztof Wójcik, Jacek Musiał, et al.
Rheumatology Advances in Practice|January 23, 2025
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) studySaadia Sasha Ali, Christiana Demetriou, Ioannis Parodis, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
Rheumatology International|November 15, 2021
COVID-19 vaccination in autoimmune disease (COVAD) survey protocolParikshit Sen, Latika Gupta, James B Lilleker, et al.
Rheumatology Advances in Practice|April 21, 2025
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey datasetVincenzo Venerito, Sergio Del Vescovo, Sergio Prieto-González, et al.
Rheumatology (Oxford, England)|June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD studyParikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
Frontiers in Immunology|October 10, 2022
COVID-19 in unvaccinated patients with inborn errors of immunity-polish experienceSylwia Kołtan, Marcin Ziętkiewicz, Elżbieta Grześk, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Medicina (Kaunas, Lithuania)|April 30, 2021
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell ArteritisCiro Manzo, Maria Maslinska, Alberto Castagna, et al.
Rheumatology International|May 13, 2026
Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohortNelly Ziade, Ihsane Hmamouchi, Marc Moussallem, et al.
Frontiers in Medicine|August 22, 2024
Increased interest with the introduction of fast-track diagnostic pathway is associated with the regionally increased frequency of giant cell arteritis in Poland: a study based on POLVAS registry dataMarcin Milchert, Krzysztof Wójcik, Jacek Musiał, et al.
Rheumatology Advances in Practice|January 23, 2025
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) studySaadia Sasha Ali, Christiana Demetriou, Ioannis Parodis, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
Rheumatology International|November 15, 2021
COVID-19 vaccination in autoimmune disease (COVAD) survey protocolParikshit Sen, Latika Gupta, James B Lilleker, et al.
Rheumatology Advances in Practice|April 21, 2025
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey datasetVincenzo Venerito, Sergio Del Vescovo, Sergio Prieto-González, et al.
Rheumatology (Oxford, England)|June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD studyParikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
Frontiers in Immunology|October 10, 2022
COVID-19 in unvaccinated patients with inborn errors of immunity-polish experienceSylwia Kołtan, Marcin Ziętkiewicz, Elżbieta Grześk, et al.
Pageof 8